26-Apr-2024
19 out 20 S&P 500 healthcare companies beat profit estimates - Earnings Scorecard
Seeking Alpha News (Fri, 26-Apr 12:56 PM ET)
Merck & Company: A Strong Buy on Robust Performance and Future Growth Prospects
TipRanks (Fri, 26-Apr 8:16 AM ET)
Merck & Co. Outperforms with Strong Keytruda Sales and Raised Guidance: A Buy Rating Affirmed
TipRanks (Fri, 26-Apr 7:25 AM ET)
TipRanks (Fri, 26-Apr 6:30 AM ET)
Merck & Company (MRK) Gets a Buy from Barclays
TipRanks (Fri, 26-Apr 4:48 AM ET)
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
Benzinga (Fri, 26-Apr 2:59 AM ET)
Bristol-Myers posts Q1 beat despite growth headwinds
Seeking Alpha News (Thu, 25-Apr 7:56 AM ET)
MRK Earnings: Merck Delivers Q1 Earnings Beat
TipRanks (Thu, 25-Apr 7:42 AM ET)
Merck raises guidance as Keytruda sales jump 20% in Q1
Seeking Alpha News (Thu, 25-Apr 7:10 AM ET)
Options Volatility and Implied Earnings Moves Today, April 25, 2024
TipRanks (Thu, 25-Apr 7:05 AM ET)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Merck Common (New) trades on the NYSE stock market under the symbol MRK.
As of April 26, 2024, MRK stock price climbed to $131.20 with 7,216,938 million shares trading.
MRK has a beta of 0.16, meaning it tends to be less sensitive to market movements. MRK has a correlation of 0.01 to the broad based SPY ETF.
MRK has a market cap of $332.46 billion. This is considered a Mega Cap stock.
Last quarter Merck Common (New) reported $16 billion in Revenue and $2.07 earnings per share. This beat revenue expectation by $575 million and exceeded earnings estimates by $.20.
In the last 3 years, MRK stock traded as high as $133.10 and as low as $15.32.
The top ETF exchange traded funds that MRK belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
MRK stock has underperformed the market in the last year with a return of +18.3%, while SPY returned +27.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MRK shares. However, MRK has outperformed the market in the last 3 month and 2 week periods, returning +9.2% and +4.3%, while SPY returned +4.6% and -0.5%, respectively. This indicates MRK has been having a stronger performance recently.
MRK support price is $129.23 and resistance is $132.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRK stock will trade within this expected range on the day.